Has Raj Murthy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $23,808 in general payments to Raj Murthy, MD across 246 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raj Murthy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raj Murthy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raj Murthy, MD

Pain Medicine · New York, NYNPI 1154776771

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Abbott at 34.9% of the total. Reporting peaked in 2024 at $10,421 and has fallen 66.5% since, to $3,496 in 2025. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,808in general payments, 2019–2025

Across 246 payments — averaging $96.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$8K
Boston Scientific$6K
Medtronic$2K
Curonix LLC$2K
MML US, Inc.$1K
Nevro Corp.$1000
plus $3K from 12 others

What the payments were for

Travel & lodging$12,07051%
Food & beverage$11,44448%
Education$2931%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	84	$8,316
Boston Scientific	74	$6,217
Medtronic	23	$2,306
Curonix LLC	10	$2,196
MML US, Inc.	4	$1,047
Nevro Corp.	13	$1,000
Relievant Medsystems, Inc.	8	$977
Orthofix Medical, Inc.	6	$389
Painteq LLC	4	$359
Si-bone, Inc.	2	$201
SPR Therapeutics, Inc	3	$160
Vertos Medical, Inc.	5	$149
Stimwave Technologies Incorporated	2	$138
Neurelis, Inc.	1	$125
Spinal Simplicity, LLC	3	$97
Stryker	2	$75
CSL Behring	1	$36
Lemaitre Vascular, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROCLAIM$5,752
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,935
Intracept$1,731
SYNCHROMEDII$1,382
ReActiv8$926
Omnia$457
WAVEWRITER ALPHA$383
GENERAL PAIN MANAGEMENT$369
INTELLIS ADAPTIVESTIM$291
Proclaim IPG$256
ETERNA$253
Physio-Stim$235
Axium$217
PAINTEQ$155
VANTA ADAPTIVESTIM$151
SPECTRA WAVEWRITER$130
Superion Indirect Decompression System$119
OCTRODE$101

How this compares

$23,808 in reported general payments places this provider in the 90th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York →

Medicare billing

Part B allowed, 2024

$118,665

Medicare patients

207

Services billed

774

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	348	$2,889
Methocarbamol	60	$1,009
Diclofenac Sodium	16	$461
Meloxicam	115	$430
Duloxetine Hcl	29	$346
Pregabalin	13	$331
Oxycodone Hcl	30	$309
Ibuprofen	11	$218
Tizanidine Hcl	18	$210
Cyclobenzaprine Hcl	15	$148
Methylprednisolone	12	$68

Paid to pharmacies, not to this prescriber.

Other pain medicine in New York

Amitabh GulatiNew York$614K
David SpinnerNew York$391K
Eric LeeNew York$117K
Christopher GhariboNew York$91K
Randa JaafarNew York$87K
Boris LeybelNew York$58K
Chirag ShahNew York$48K
Annie Layno-MosesNew York$29K
David CassagnolNew York$22K
Scott MaddaloNew York$22K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →